Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-24-066738
Filing Date
2024-05-30
Accepted
2024-05-30 17:18:18
Documents
14
Period of Report
2024-03-13
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2416013d1_8ka.htm   iXBRL 8-K/A 31823
2 EXHIBIT 99.3 tm2416013d1_ex99-3.htm EX-99.3 54787
  Complete submission text file 0001104659-24-066738.txt   269209

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fwbi-20240313.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fwbi-20240313_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fwbi-20240313_pre.xml EX-101.PRE 22367
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2416013d1_8ka_htm.xml XML 3686
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37853 | Film No.: 241006651
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)